AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,445,000 | -69.3% | 117,434 | -69.3% | 0.56% | -69.3% |
| Q3 2016 | $14,459,000 | +128.2% | 383,118 | +6.4% | 1.82% | +102.1% |
| Q2 2016 | $6,336,000 | +37.1% | 360,004 | -5.3% | 0.90% | +47.4% |
| Q1 2016 | $4,623,000 | +9.9% | 380,190 | +120.1% | 0.61% | +23.5% |
| Q4 2015 | $4,207,000 | -21.3% | 172,763 | -42.7% | 0.49% | -20.3% |
| Q3 2015 | $5,345,000 | +75.9% | 301,293 | +75.1% | 0.62% | +100.6% |
| Q2 2015 | $3,038,000 | – | 172,115 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |